Laurie Bailey, MD
Laurie Bailey, MD, is the first Aurora Women's Health fellow, and a certified NAMS Menopause Practitioner. She graduated from the St. Luke's Family Medicine Residency program prior to joining Aurora. Dr. Bailey is a member of International Society for the Study of Women's Sexual Health, and the North American Menopause Society.  

Dr. Bailey received her MD from the Medical College of Wisconsin and completed her Family Practice residency and a Women’s Health fellowship at St. Luke's Family Practice program. She is board certified in Family Medicine.

Gus Alva, MD
Gus Alva, MD, is the Medical Director of ATP Clinical Research in Costa Mesa, California, a premiere private neuropsychiatric clinical research group; prior to founding ATP Clinical Research, he served as Associate Professor and Deputy Director of the Clinical Research Division in the Department of Psychiatry and Human Behavior at the University of California, Irvine. Dr. Alva is a Distinguished Fellow of the American Psychiatric Association, a Diplomate of the American Board of Psychiatry and Neurology and a Diplomate of the American Board of Geriatrics. He is also a forensic psychiatric consultant for the Orange County Superior Court.  

Dr. Alva received his medical degree from the Autonomous University of Guadalajara in Mexico. He completed his residency training at the University of California, Irvine Medical Center in the Department of Psychiatry and Human Behavior, serving as Chief Resident in his last year and joining the faculty immediately after, to support the clinical research efforts of the department.  

As a clinician and investigator, Dr Alva’s focus is on the genetics, neuroimaging, aspects of ethnicity and their correlation within clinical situations, and treatments for various psychiatric disorders. He has published numerous articles and presents at both national and international meetings and conferences. For the past 12 years, Dr. Alva has served as a principal investigator for multiple trials on various neuropsychiatric conditions and their treatments, including Alzheimer’s disease, depression, anxiety disorders, bipolar disorder, and psychotic conditions.  

Dr. Alva is a Past-President of the Orange County Psychiatric Society, and is a member of many professional organizations, including the American Medical Association, the Orange County Medical Association, the California Psychiatric Association, the American Board of Forensic Medicine, the American College of Forensic Examiners, and the California Hispanic American Medical Association. He is also a founding member of the International Congress of Geriatric Psychopharmacology.

Kirsten Fleming, PhD
Kirsten Fleming, PhD, attended college at the University of California, Berkeley, and received her PhD in clinical psychology from the California School of Professional Psychology, Los Angeles, California. Dr. Fleming spent ten months at the Long Beach Veteran's Administration Medical Center involved in post-doctoral work in neuropsychology, primarily working with rehabilitation patients. To obtain further training in neuroscience, she obtained an Intramural Research Training Award at the National Institute of Mental Health where she spent the next four years studying schizophrenia, bipolar disorder, borderline disorder, brain injury and brain imaging. Dr. Fleming then accepted an Assistant-Associate Professor position at the University of California/Irvine (UCI), Department of Psychiatry where she established a Neuropsychology Laboratory from 1995-2006. At UCI, she worked extensively on clinical trials establishing the efficacy of several new treatments for Alzheimer's disease, schizophrenia and depression, and was the Principal Investigator/Co-Investigator for numerous studies and grants examining the novel use of neurotrophic factor and combined therapy in treating schizophrenia. In addition, she completed several projects studying various aspects of dementia and mental illness.  

Dr. Fleming has worked as a consultant over the past ten years with pharmaceutical companies in aiding them design cognitive components for international studies, trained individuals at meetings as to how to perform neuropsychological assessments, analyzed large-scale data from studies, written publications, and presented findings at national and international scientific meetings. In 2006, she spent seven months at California Clinical Trials, Glendale teaching staff how to perform psychiatric and cognitive rating scales and developed an inter-rater training program for them.  

Since the late 1990s, Dr. Fleming has been involved with the Orange County Alzheimer's Association, where she is a member of their Medical/Scientific Advisory Board. She often speaks to various groups on dementia, Alzheimer's disease and how to preserve brain skills (Maintain Your Brain campaign). In addition, her forensic work has consisted primarily on conducting neuropsychological evaluations on individuals involved in criminal trials to determine whether neurologic deficits may have contributed to the inmates’ actions.